Clinical trial
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR in Patients With Upper Respiratory Infection, Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in the Czech Republic
NCT01130883 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR in Patients With Upper Respiratory Infection, Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in the Czech Republic
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- July 31, 2010
- Enrollment
- 3,130 (actual)
- Sites
- 135
Conditions
As the registry lists them; a condition with its own page is linked.
bronchitis, chronic bronchitis, community-acquired pneumonia (cap), tracheitis, tracheobronchitis